MK-2206 2HCl

Catalog No.S1078

MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM in cell-free assays, respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.

Price Stock Quantity  
USD 220 In stock
USD 110 In stock
USD 170 In stock
USD 370 In stock
USD 570 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

MK-2206 2HCl Chemical Structure

MK-2206 2HCl Chemical Structure
Molecular Weight: 480.39

Validation & Quality Control

Cited by 178 publications:

18 customer reviews :

Quality Control & MSDS

Related Compound Libraries

MK-2206 2HCl is available in the following compound libraries:

Akt Inhibitors with Unique Features

  • Selective Akt Inhibitor

    CCT128930 AKT2-selective, IC50=6 nM.

  • Most Potent Akt Inhibitor

    AZD5363 Akt1, IC50=3 nM; Akt2, IC50=8 nM; Akt3, IC50=8 nM.

  • Akt Inhibitor in Clinical Trial

    Perifosine (KRX-0401) Phase III fro relapsed and refractory multiple myeloma.

  • Newest Akt Inhibitor

    AZD5363 Potent inhibitor of all isoforms of Akt (Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM, similar to P70S6K/PKA and lower activity towards ROCK1/2.

Product Information

  • Compare Akt Inhibitors
    Compare Akt Products
  • Research Area
  • Inhibition Profile
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM in cell-free assays, respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.
Targets Akt1 [1]
(Cell-free assay)
Akt2 [1]
(Cell-free assay)
Akt3 [1]
(Cell-free assay)
IC50 8 nM 12 nM 65 nM
In vitro MK-2206 is an allosteric inhibitor and is activated by the pleckstrin homology domain. MK-2206 inhibits auto-phosphorylation of both Akt T308 and S473. MK-2206 also prevents Akt-mediated phosphorylation of downstream signaling molecules, including TSC2, PRAS40 and ribosomal S6 proteins. [1] MK-2206 inhibits Ras wild-type (WT) cell lines (A431, HCC827, and NCI-H292) more potently when compared to Ras-mutant cell lines (NCI-H358, NCI-H23, NCI-H1299, and Calu-6). MK-2206 also shows synergistic responses in combination with cytotoxic agents such as erlotinib or lapatinib in lung NCI-H460 or ovarian A2780 tumor cells. [2] MK-2206 or siRNA-mediated Akt inhibition strongly activates autophagy in human glioma cells. However, eukaryotic elongation factor-2 (eEF-2) silencing suppresses MK-2206-induced-autophagy, with a promotion of apoptotic cell death. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
NCI-H292NGHuTIdEgXSxdH;4bYMhSXO|YYm=M{TWcVMh|ryPNHXyVXo4OiCqMkjnSG1UVw>?Mm\iTY5pcWKrdHnvckBw\iClZXzsJJBzd2yrZnXyZZRqd25?MnLrNlA2PzFyNkm=
A431NUfpeZlQU2mwYYPlJGF{e2G7MlTXOUDPxE1?MYO1JIg>MoWzSG1UVw>?NHr3NHlUfXCycnXzd4V{KHSqZTDzbYdv[Wyrbnegc4YhSWu2IHHu[EBGemt?M3HiflIxPTdzME[5
HepG2M1G2b2N6fG:2b4jpZ{BCe3OjeR?=NX\QVnJuOTBizszNMlzzNlQhcA>?NX[4dXJOTE2VTx?=MV\T[Y5{cXSrenXzJJJme2m|dHHueEBk\WyuczD0c{B1cGViY4n0c5RwgGmlIHXm[oVkfCCxZjDzc5Ji\mWwaXK=M1jKbFIyOjB3OUK1
Sk-Hep1NVrDTIpjS3m2b4TvfIlkKEG|c3H5NHnhU2MyOCEQvF2=NFLONmczPCCqMUDEUXNQNH;rZplU\W6|aYTpfoV{KHKnc3nzeIFvfCClZXzsd{B1dyC2aHWgZ5l1d3SxeHnjJIVn\mWldDDv[kB{d3KjZnXubYI>NGn2fFQzOTJyNUmyOS=>
OCUT1 cells harbored PIK3CA (H1047R+/+)MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWK2VpJIOyEQvF2=M17USVUh\A>?M2j6[mROW09?NGruO2xKSzVyPUCuNVQh|ryPMYWyNVI5QTJ4Nx?=
K1 cells harbored PIK3CA (E542K+/+)Mo\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUGyZ5pWOyEQvF2=NXnjRW4zPSCmNYjleYFrTE2VTx?=NF\oc4hKSzVyPUCuOVIh|ryPMmjjNlEzQDl{Nke=
FTC133 cells harbored PTEN (allele deletion and R130+)MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIq0NmE{KM7:TR?=NWDWSGsxPSCmMlnMSG1UVw>?M1y0d2lEPTB;MD6xPEDPxE1?M4jYOFIyOjh7Mk[3
C643 cells harbored HRAS (G13R+/−)MnjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\zN{DPxE1?NX7qSVlHPSCmMk[zSG1UVw>?NWLkdJFRUUN3ME2wMlI4KM7:TR?=NUDKUZBKOjF{OEmyOlc>
Hth7 cells harbored NRAS (Q61R+/−)M33aOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoD0N{DPxE1?NXPDeYtOPSCmNXHucXpRTE2VTx?=NETMUmJKSzVyPUSuOUDPxE1?MYmyNVI5QTJ4Nx?=
TPC1 cells harbored RET/PTC1 rearrangementNEe0[nFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4D6UlMh|ryPMWS1JIQ>NUjOXI56TE2VTx?=MXrJR|UxRTBwNUmg{txOMUKyNVI5QTJ4Nx?=
Hth74MmfXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHlPWY{KM7:TR?=M1TyblUh\A>?M2LEbWROW09?NEHQdYRKSzVyPUKuNVkh|ryPNGD5Z2IzOTJ6OUK2Oy=>
KAT18NH7WfotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjhN{DPxE1?NFHZVWU2KGR?NVjXdJBITE2VTx?=MXnJR|UxRTRwNkKg{txOMmfaNlEzQDl{Nke=
SW1736MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoSzNVAxKM7:TR?=M4nDb|Uh\A>?NYPx[pdWTE2VTx?=MlnQTWM2OD12Nz61OkDPxE1?M2fzcVIyOjh7Mk[3
WRONWSyPXFoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfGNVAxOCEQvF2=MmXqOUBlNIPGflFFVVORNFLVXVhKSzVyPkGwNFAh|ryPMWqyNVI5QTJ4Nx?=
TAD2NIqyS5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXr6TZJvOTByMDFOwG0>MknYOUBlMonRSG1UVw>?NFX5ZXpKSzVyPkGwNFAh|ryPNHrZb5EzOTJ6OUK2Oy=>
LN229NYPzVnl1SXCxcITvd4l{KEG|c3H5MojQNE42KM7:TR?=M3HKR|YxKGh?MXnEUXNQM1fmXWF2\22nboTzJIFxd3C2b3flcolkKGWoZnXjeJMhd2ZiZ3XmbZRqdmmkMY[yNlA2PzlzNB?=
T98GMnnHRZBweHSxc3nzJGF{e2G7M4rtblAvPSEQvF2=MlTsOlAhcA>?MYnEUXNQMWrBeYdu\W62czDhdI9xfG:pZX7pZ{Bm\m[nY4TzJI9nKGenZnn0bY5q[g>?MUmyNlA2PzlzNB?=
HC11MWHGeY5kfGmxbjDBd5NigQ>?MVKxNEDPxE1?NFPpdXkzPCCqNFzz[YJFVVORNIexXG5KdmirYnn0d{DPui2lYYPlbY4h[W6mIFHEVnAhe3mwdHjld4l{MonINlI1OjZ4MkG=
MOLT-4M4nCR2N6fG:2b4jpZ{BCe3OjeR?=MYOxNEDPxE1?MnnvOFghcA>?MWXEUXNQMYrJR|UxRTFwN,MAje69VQ>?NYH1XpJqOjJ4MUSyOFM>
CEM-RNXnZOZhHS3m2b4TvfIlkKEG|c3H5NX\STndVOTBizszNMWi0PEBpNIX1eFhFVVORMXLJR|UxRTNwM,MAje69VQ>?Mk[0NlI3OTR{NEO=
CEM-SMUPDfZRwfG:6aXOgRZN{[Xl?M3vuNFExKM7:TR?=MXy0PEBpMorlSG1UVw>?NEn4SW1KSzVyPUWuNgKBkc7:TR?=M13TZlIzPjF2MkSz
MOLT-4M13zbWZ2dmO2aX;uJGF{e2G7M33PR|ExKM7:TR?=M4fETlI1KGh?NInSdJZFVVORMl\vRoxw[2u|IHPlcIx{KGmwIITo[UBIOC:JMTDwbIF{\SCxZjD0bIUh[2WubDDjfYNt\Q>?NYO4eIJ5OjJ4MUSyOFM>
MOLT-4NUXmPZBXTnWwY4Tpc44hSXO|YYm=NHHHbms16oDLzszNM13Tc|QhcA>?NX3FcmtLTE2VTx?=NEnybZFKdmO{ZXHz[ZMhfGinIHHtc5VvfCCxZjDjcIVifmWmIFzDN2EwSixiYTD3[YxtNWW|dHHicIl{cGWmIHH1eI9xcGGpeTDtZZJs\XJ?NIPTbVkzOjZzNEK0Ny=>
CEM-RMWnGeY5kfGmxbjDBd5NigQ>?NHTRcJM16oDLzszNMn;ZOEBpMl3zSG1UVw>?M2KwdWlv[3KnYYPld{B1cGViYX3veY51KG:oIHPs[YF3\WRiTFO0RU9DNCCjIIflcIwu\XO2YXLsbZNp\WRiYYX0c5Bp[We7IH3hdotmeg>?MonmNlI3OTR{NEO=
CEM-SNFPDcVlHfW6ldHnvckBCe3OjeR?=NF\vdYg16oDLzszNM4TyUVQhcA>?M{TxPGROW09?MnPDTY5kemWjc3XzJJRp\SCjbX;1cpQhd2ZiY3zlZZZm\CCOQ{XBM2ItKGFid3XscE1me3SjYnzpd4hm\CCjdYTvdIhi\3libXHyb4VzNHjLNHozOjZzNEK0Ny=>
HepG2 cellNUPBdJNbU2mwYYPlJGF{e2G7M2jpTVIxKM7:TR?=M2n3NlI1KGh?NFvPfIlFVVORM1rWUWRwf26{ZXf1cIF1\XNidHjlJJBpd3OyaH;yfYxifGmxbjDv[kBCU1R?MmfUNlM4QTd|MUm=
HepG2 cellMoXtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTkZlBTOzBizszNNUPZR4ZEOjRiaB?=NF73N2xFVVORMYDJcohq[mm2czDj[YxtKGe{b4f0bC=>NIPL[oEzOzd7N{OxPS=>
HepG2 cellMVrBdI9xfG:|aYOgRZN{[Xl?NXLwNot3OjBizszNMXmyOEBpMUDEUXNQNGPRPW9KdmS3Y3XzJINmdGxiYYDvdJRwe2m|MUOyN|c6PzNzOR?=
GEOMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3n1[|UxOCCwTR?=NITBRlM4OiCqMVLEUXNQMoPVTY5pcWKrdIOgZ4VtdCCpcn;3eIg>NUXoUVZKOjR3OEGyN|E>
CNE-1M2faZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUWxNEDPxE1?MkjxPVYhcA>?MV;EUXNQNX3CNVZkUUN3ME2yMlk3KM7:TR?=MWiyOVM{Pjl{NR?=
CNE-2MnnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTNNVAh|ryPNYLqPJhtQTZiaB?=Ml[wSG1UVw>?NXv4N5RsUUN3ME20MlU{KM7:TR?=MmXuNlU{OzZ7MkW=
HONE-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX7DNZY2OTBizszNMl\MPVYhcA>?M4fBOmROW09?M1jsVGlEPTB;Mz6zO{DPxE1?MW[yOVM{Pjl{NR?=
SUNE-1MoD6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHi4TmMyOCEQvF2=NWG4VG9RQTZiaB?=NEXJdlJFVVORMWjJR|UxRTBwNUKg{txONFm5PFYzPTN|NkmyOS=>
CNE-2NGDOZpZHfW6ldHnvckBCe3OjeR?=NFyzSpYyOCEQvF2=NIfqSGc1QCCqMYLEUXNQM4\kOmlv\HWlZYOgZ4VtdCCleXPs[UBienKnc4SgZZQhTzF?NEPuW|MzPTN|NkmyOS=>
HONE-1MV7GeY5kfGmxbjDBd5NigQ>?NUWzWnZUOTBizszNNGHzdpc1QCCqMUTEUXNQNXrufHZqUW6mdXPld{Bk\WyuIHP5Z4xmKGG{cnXzeEBifCCJMR?=MkGyNlU{OzZ7MkW=
NEC8M3P6d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH:5WWtKSzVyPUCuNFk3PTFizszNNF\JOI5USU6JRWK=
P12-ICHIKAWAMmTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnLRTWM2OD1yLkGxOlIh|ryPMlHGV2FPT0WU
MDA-MB-175-VIIMoC2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\NNGlEPTB;MD6xN|c{QCEQvF2=MVvTRW5ITVJ?
AsPC-1NIC1WW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2[4O2lEPTB;MD6yNlEzOiEQvF2=Mmi0V2FPT0WU
T47DNH7Bc49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMkiyOUDPxE1?NWPScpVVW0GQR1XS
HHMoD4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTBwM{CyPFMh|ryPNEnMWldUSU6JRWK=
MOLT-16NUHkSFExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3S4SWlEPTB;MD6zNFMzKM7:TR?=NFfJT2lUSU6JRWK=
ES5NGXrNW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn64TWM2OD1yLkO0OFU2KM7:TR?=NGf1S3JUSU6JRWK=
RS4-11Ml[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{T1PWlEPTB;MD6zOFYyKM7:TR?=M4X1enNCVkeHUh?=
KARPAS-45NVXQboZtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYXJR|UxRTBwM{ezNlEh|ryPNIPDRpBUSU6JRWK=
NCI-H720MnjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrpN45KSzVyPUCuN|c3PzlizszNNIHVdZRUSU6JRWK=
H9MmHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4jhTWlEPTB;MD6zPFg5OyEQvF2=NVG2SZlRW0GQR1XS
EFM-19MonlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoXCTWM2OD1yLkS0NFEh|ryPMkCzV2FPT0WU
SBC-1NHHpW41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnqNJo3UUN3ME2wMlQ1ODN3IN88US=>NXP6TIpUW0GQR1XS
A4-FukNXjZPGhzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoL5TWM2OD1yLkS2PFY5KM7:TR?=NGLlSHlUSU6JRWK=
NCI-H1563NETIZ29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXGTWM2OD1yLkS4NVg6KM7:TR?=NXrCWIZ4W0GQR1XS
HCC1419NV7pdIlpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoTITWM2OD1yLkS4PFkzKM7:TR?=NH\meZZUSU6JRWK=
H-EMC-SSMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TGVmlEPTB;MD60PVk{QSEQvF2=Ml20V2FPT0WU
BHT-101NYrRO5JRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFy5SFJKSzVyPUCuOVI6PjFizszNMmTEV2FPT0WU
IGROV-1M{HrUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHe1d4NKSzVyPUCuOVUzPDlizszNNUn0[JNkW0GQR1XS
HGC-27NV3VW4p7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2LHbmlEPTB;MD61Olc5OyEQvF2=M4T5N3NCVkeHUh?=
MDA-MB-361NHnsRY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HSemlEPTB;MD61O|c3OSEQvF2=MoHIV2FPT0WU
KE-37NV;Zb4pFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TCNGlEPTB;MD61PFI3KM7:TR?=NUW0Z3A5W0GQR1XS
HCC70NWPPfXJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4D3XmlEPTB;MD61PVgzPyEQvF2=MnHvV2FPT0WU
LNCaP-Clone-FGCNFL2OWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFHO[4dKSzVyPUCuOlExPDhizszNMkP4V2FPT0WU
HAL-01NHS1Z5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWG4XnZ6UUN3ME2wMlYzOTNizszNNIe3TY1USU6JRWK=
HTMnS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTBwNkOyN|kh|ryPMofsV2FPT0WU
MDA-MB-415NFe5VlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{PsNGlEPTB;MD62N|YzPiEQvF2=NILLVolUSU6JRWK=
NOS-1Ml;1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTBwNkO3NlMh|ryPM1f2bnNCVkeHUh?=
DU-145MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTBwNkS3OFUh|ryPNIPqfHZUSU6JRWK=
OCUB-MM1jzV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmruTWM2OD1yLkewPVY3KM7:TR?=MkPFV2FPT0WU
VA-ES-BJNH32[WJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NID4[HJKSzVyPUCuO|MxOjVizszNMnHWV2FPT0WU
J-RT3-T3-5NF7YfllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3KzUWlEPTB;MD63OFQxOyEQvF2=M2DFU3NCVkeHUh?=
MOLT-4NXPNSopGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFrBVVNKSzVyPUCuPFA2QDJizszNMnX2V2FPT0WU
NB7MnLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33oU2lEPTB;MD64NlQyOSEQvF2=NWXXTnUxW0GQR1XS
L-363M4nWZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3vxcGlEPTB;MD64N|Q1OiEQvF2=M3j0enNCVkeHUh?=
NKM-1MnO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrTTWM2OD1yLki2NlU{KM7:TR?=M4j4THNCVkeHUh?=
HOP-92NGrPPJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTBwOEeyNlMh|ryPNU\QWG9LW0GQR1XS
OAW-42NF7jUIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTBwOEi3NkDPxE1?NUTFboszW0GQR1XS
HuO9M1;QNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGmwVWFKSzVyPUCuPVI4PTFizszNNVzZeFh7W0GQR1XS
MFE-280M{HnSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnm5TWM2OD1yLkm2OFY2KM7:TR?=M1HXeHNCVkeHUh?=
EM-2MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTBwOUe5N|kh|ryPNHL5XnVUSU6JRWK=
NCI-H520MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HwfGlEPTB;MD65PFU6OiEQvF2=MV3TRW5ITVJ?
LB2241-RCCM4jjT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTBwOUm3N|Qh|ryPM2W5XHNCVkeHUh?=
SK-NEP-1NHfJVZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV21[|FlUUN3ME2xMlE1PDh3IN88US=>NV;oVmJtW0GQR1XS
LXF-289M2HK[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYPaWohoUUN3ME2xMlE4OTV4IN88US=>MoP3V2FPT0WU
EPLC-272HMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2nNbGlEPTB;MT6xO|I2PiEQvF2=Mk\xV2FPT0WU
COLO-684MoH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLLRW5KSzVyPUGuNlM4OjVizszNNYPme|ZrW0GQR1XS
ES1M{f4O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NY[4ZohqUUN3ME2xMlI1ODZ3IN88US=>M1njd3NCVkeHUh?=
DOHH-2NUDHXXB4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVXmdVNJUUN3ME2xMlI5OjB|IN88US=>NUTGNm9QW0GQR1XS
CTB-1MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPtTWM2OD1zLkK4PVkh|ryPMV\TRW5ITVJ?
G-401M37Kb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHvwZ2xKSzVyPUGuNlk4QTVizszNNWjvUVVVW0GQR1XS
LoVoMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTFwM{K1N|Qh|ryPM{fkUnNCVkeHUh?=
Ramos-2G6-4C10MlHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHWTWM2OD1zLkOzO|AyKM7:TR?=MmrqV2FPT0WU
MFM-223NHvUOYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIDOSlVKSzVyPUGuN|Q1PjFizszNM1TCO3NCVkeHUh?=
PA-1MmL0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTFwM{WyOlUh|ryPMnXBV2FPT0WU
697MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;OW2lEPTB;MT6zO|YyPiEQvF2=NVj5VXo{W0GQR1XS
QIMR-WILM3nJOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTFwNEmxNVYh|ryPM1;FXnNCVkeHUh?=
HOSMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmryTWM2OD1zLkS5OVU5KM7:TR?=NGrWbJJUSU6JRWK=
DMS-273NVzVdWFFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXq4WnRWUUN3ME2xMlUyQTV7IN88US=>MV;TRW5ITVJ?
ME-180NF;PUFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXT[JdjUUN3ME2xMlU3QDlzIN88US=>NYDVZXZnW0GQR1XS
HCC2218MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLoTWM2OD1zLk[4NlI2KM7:TR?=NV\J[IQ4W0GQR1XS
CAL-54NGjJbYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\LTlJKSzVyPUGuO|EzPDJizszNMV7TRW5ITVJ?
OMC-1M3fMT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2fwPWlEPTB;MT63OFY4PyEQvF2=MmmwV2FPT0WU
COR-L105Mn7VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoGyTWM2OD1zLke5O|M4KM7:TR?=M1TIT3NCVkeHUh?=
BV-173MnjXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTFwOEGwO|Qh|ryPNYHVSXdQW0GQR1XS
RKONIjrfIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUmxVYJWUUN3ME2xMlg4OTBzIN88US=>NUXiN2NvW0GQR1XS
SNU-387NHnXXGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIX6TGFKSzVyPUGuPFg1ODZizszNNVrhTGhnW0GQR1XS
SW1088NIi3UFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnuUVRxUUN3ME2xMlk1PjB4IN88US=>NVuydVRoW0GQR1XS
Hs-578-TM1Tjb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPFZ3ZKSzVyPUKuNVE1OzNizszNNHLpOZNUSU6JRWK=
OC-314NIfmdG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\TWXVKSzVyPUKuNVUxQDZizszNMkLmV2FPT0WU
RMG-IMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PHdmlEPTB;Mj6xOlM6QCEQvF2=MXPTRW5ITVJ?
NCI-H1395MoL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2P3fmlEPTB;Mj6xPFA6OSEQvF2=NHK3[4dUSU6JRWK=
GAMGNGjYXpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTJwMkO4OFUh|ryPMoX1V2FPT0WU
LB1047-RCCNUTtcVVxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4fGXWlEPTB;Mj6yOFMyPyEQvF2=M17BXHNCVkeHUh?=
MN-60MlXiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7XWVVKSzVyPUKuNlk6OjNizszNNGPH[WdUSU6JRWK=
OAW-28Mn\5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHGw[5ZKSzVyPUKuNlk6PTFizszNMVfTRW5ITVJ?
NCI-H2228MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDNPXFmUUN3ME2yMlMyPTV{IN88US=>NHX0TodUSU6JRWK=
ABC-1Mn60S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkCzTWM2OD1{LkOzNlU{KM7:TR?=M2jBU3NCVkeHUh?=
LS-513MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2XTZ2lEPTB;Mj6zN|Q5PCEQvF2=NFWwPG5USU6JRWK=
KS-1NWPEZ5BnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlGxTWM2OD1{LkO4NVkyKM7:TR?=M17KenNCVkeHUh?=
NB69NY\WUo9rT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXu0Om5PUUN3ME2yMlM5QTh|IN88US=>NFLCW2tUSU6JRWK=
VM-CUB-1NUfiZWhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXnTWM2OD1{LkO5NFg{KM7:TR?=M4PvUnNCVkeHUh?=
D-423MGMlq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUnJR|UxRTJwNEGwOFQh|ryPNVXUe|JIW0GQR1XS
EW-18MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTJwNEG5N|kh|ryPM2n3NnNCVkeHUh?=
YH-13NVLod2pjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFzYdpZKSzVyPUKuOFYyPTNizszNNIrlco5USU6JRWK=
T-24MnHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYjnSIdyUUN3ME2yMlQ4QDhzIN88US=>NVPLToN6W0GQR1XS
ES8NGm5OHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1u3dWlEPTB;Mj60PVI5PyEQvF2=NWG0e|d3W0GQR1XS
ES3NHnjRZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1TzcGlEPTB;Mj60PVc2QSEQvF2=MnfPV2FPT0WU
RXF393NHPqblBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVHJR|UxRTJwNkC0PFch|ryPMVTTRW5ITVJ?
RPMI-8226M1\oeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVXiR3Y6UUN3ME2yMlYzQTV|IN88US=>NXr4W3h7W0GQR1XS
AGSMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmT6TWM2OD1{LkeyNVM4KM7:TR?=Mm\JV2FPT0WU
HCC1395MoqyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M13lWWlEPTB;Mj63OVE5PyEQvF2=NUXnW4tPW0GQR1XS
MV-4-11MlroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1m2fmlEPTB;Mj63OVI3PiEQvF2=MXjTRW5ITVJ?
A204NYGwZ5RQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XhfWlEPTB;Mj64N|g4OiEQvF2=MXjTRW5ITVJ?
MCF7MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEn4dnNKSzVyPUKuPFYyOTdizszNNVzCeJNvW0GQR1XS
SNU-423MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTJwOEmyOFIh|ryPM2ToPXNCVkeHUh?=
NCI-H1048M1;HXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDEWGRpUUN3ME2yMlk3QDZ3IN88US=>NXe5e45iW0GQR1XS
GR-STNWfmfZM4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{PwRWlEPTB;Mz6wOFYyOSEQvF2=Mo\jV2FPT0WU
EoL-1-NWHs[JJtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHITWM2OD1|LkC3NFU5KM7:TR?=MmPNV2FPT0WU
HuH-7M3HJV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTNwMEm0OlQh|ryPNVj1RWZFW0GQR1XS
OS-RC-2NVzZbpVHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XTOWlEPTB;Mz6xNVE6KM7:TR?=M4fBNnNCVkeHUh?=
EW-3MonlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUTJR|UxRTNwMUm1Nlkh|ryPNIfJcpZUSU6JRWK=
NCI-H747M2\xbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTNwMkC2PVQh|ryPMnjjV2FPT0WU
EW-16MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHsRmJXUUN3ME2zMlIyQDd7IN88US=>MnH5V2FPT0WU
DOKMmLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\pTWM2OD1|LkKyPFU6KM7:TR?=NX7yblVsW0GQR1XS
HCC2157MmS5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWjQZlVyUUN3ME2zMlM5OTd7IN88US=>M3fKWXNCVkeHUh?=
OVCAR-3NH3j[pdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfObJh7UUN3ME2zMlQxPzh4IN88US=>MUTTRW5ITVJ?
NCI-H1623M4jnNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlHhTWM2OD1|LkSxNlI1KM7:TR?=M{HBRXNCVkeHUh?=
H4NHfkOZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzsTWM2OD1|LkS1OlI3KM7:TR?=MoW2V2FPT0WU
SW1710MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHXpWoRKSzVyPUOuOFY3PzhizszNMXLTRW5ITVJ?
RT-112NEHYWWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTNwNUKzPFgh|ryPMVTTRW5ITVJ?
DMS-114M1u3NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;5[o1mUUN3ME2zMlYzOjd6IN88US=>MmWwV2FPT0WU
AN3-CAMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Moq1TWM2OD1|Lk[yOFU3KM7:TR?=NIj0RZhUSU6JRWK=
KNS-62M37vOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFrYUXhKSzVyPUOuOlM{OzhizszNNXPCOlJtW0GQR1XS
SJRH30Ml64S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkjmTWM2OD1|Lk[5NVIzKM7:TR?=MWDTRW5ITVJ?
G-402M{nMV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEHWT5ZKSzVyPUOuO|A4OTFizszNM3\sTHNCVkeHUh?=
MHH-PREB-1NVrM[GJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M163bmlEPTB;Mz63NlA{QCEQvF2=M3m1NnNCVkeHUh?=
P30-OHKNX71SpdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33wVWlEPTB;Mz64NFk4PiEQvF2=MontV2FPT0WU
RVH-421M{joOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjlbXlKSzVyPUOuPFE4QDhizszNM1T3NnNCVkeHUh?=
LU-134-AMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUjJR|UxRTNwOEi0Nlgh|ryPNUK2U3k{W0GQR1XS
ECC10MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPsOYFKSzVyPUOuPVM3OjJizszNMWfTRW5ITVJ?
TGWNFzCdFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4PMO2lEPTB;ND6wNlMxPSEQvF2=MV;TRW5ITVJ?
MLMANXf3[Y5ET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIGwUIJKSzVyPUSuNFI6PjZizszNMXrTRW5ITVJ?
SCC-25MofMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkK3TWM2OD12LkC2OVY3KM7:TR?=MnOzV2FPT0WU
TYK-nuMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zSeGlEPTB;ND6wPVU{PCEQvF2=MoLmV2FPT0WU
LAMA-84NVu1W2xiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnL0TWM2OD12LkG0NVkyKM7:TR?=Mm\BV2FPT0WU
Calu-3MoLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUfaUmNzUUN3ME20MlI1PDF4IN88US=>NX6ycVJuW0GQR1XS
NCI-H460NFT2eHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUjjN2U4UUN3ME20MlI3PDR|IN88US=>MVfTRW5ITVJ?
EGI-1NXPzeoJvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXwTWM2OD12LkO3O|c5KM7:TR?=NWXhVVU6W0GQR1XS
NCI-H292NXraV2plT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4Dje2lEPTB;ND6zPFE1PiEQvF2=NVG4fpl{W0GQR1XS
HCE-TMoDuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTRwNEG1O|kh|ryPM{LXe3NCVkeHUh?=
EW-11MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NG\SOnNKSzVyPUSuOFE5OzhizszNMmTYV2FPT0WU
ATN-1MmH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkXuTWM2OD12LkS0N|A1KM7:TR?=M4e1NnNCVkeHUh?=
NB5NGjsZYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml3KTWM2OD12LkWzOlk4KM7:TR?=M1XmN3NCVkeHUh?=
KLENE\UW|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVXq[GttUUN3ME20MlcxOTl6IN88US=>NW\zfGJvW0GQR1XS
CAL-39M1zoWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfTSGF4UUN3ME20MlczOTR4IN88US=>Mn3NV2FPT0WU
TI-73NVnTcphnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVvJR|UxRTRwOEC2NFkh|ryPNXP3coFLW0GQR1XS
HO-1-N-1MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTESW9TUUN3ME20Mlk1OiEQvF2=NXu2T2lGW0GQR1XS
786-0MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\UR2lEPTB;ND65OFY4OyEQvF2=NIXFTI1USU6JRWK=
SK-N-DZNI[0cpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXnDT45wUUN3ME20Mlk3OTR{IN88US=>MYfTRW5ITVJ?
NCI-H446M3TOXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTVwMkCwNFkh|ryPNHTtTIJUSU6JRWK=
ETK-1M364V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTVwMkGxOlUh|ryPMVnTRW5ITVJ?
BT-20MoLDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF\USlVKSzVyPUWuNlE{PTNizszNNI[wSoFUSU6JRWK=
MEL-HONX23XFd{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoTNTWM2OD13LkO3N|M3KM7:TR?=NEXuW3dUSU6JRWK=
CAL-27MkXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzmd4hKSzVyPUWuOFY{OzlizszNM4H3UXNCVkeHUh?=
SW872NHTOPXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnq5TWM2OD13LkW5OFI5KM7:TR?=NHrPR5VUSU6JRWK=
RPMI-2650M4DqfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTVwNk[xPVkh|ryPM2XBbnNCVkeHUh?=
PFSK-1MkD6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MofmTWM2OD13LkeyO|MzKM7:TR?=NEHXb3FUSU6JRWK=
SF295MoP4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFn1PWpKSzVyPUWuPFA3OzNizszNNXTDV3k6W0GQR1XS
BeckerNXHuWpk{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTVwOE[0O|Ih|ryPNUPDTZI2W0GQR1XS
Saos-2NWD5OXJLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3LnXGlEPTB;NT64OlU{KM7:TR?=MYfTRW5ITVJ?
SK-OV-3M{DmRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX;JR|UxRTVwOUm4NVYh|ryPNV\2cnM3W0GQR1XS
VMRC-RCZNFf5dHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3frfmlEPTB;Nj6wPFc4OyEQvF2=NUXGfHdTW0GQR1XS
EW-22M2\MdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2nGUmlEPTB;Nj6xPVY1QSEQvF2=NF34bVdUSU6JRWK=
BT-474MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGS0OXpKSzVyPU[uNlM{KM7:TR?=MYXTRW5ITVJ?
BFTC-909NGTsXGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7XUlVKSzVyPU[uN|A{PDVizszNNF3Ye|JUSU6JRWK=
NB12Mof4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWH3V4ZxUUN3ME22MlM6ODdzIN88US=>M2[3VHNCVkeHUh?=
D-263MGNUK3NWlxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULmOoJFUUN3ME22MlQ2OTZ7IN88US=>M3vLe3NCVkeHUh?=
SNB75MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHPOd2RKSzVyPU[uOlAyPDNizszNNUD1S|E2W0GQR1XS
A704M2S2bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTPTWM2OD14Lk[zNFYh|ryPMWHTRW5ITVJ?
NCI-H1693MlqyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDaNYNKSzVyPU[uOlM3ODRizszNMXPTRW5ITVJ?
LN-405Mn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPITWM2OD14Lke5OlczKM7:TR?=MY\TRW5ITVJ?
CHL-1NEH0TIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlnoTWM2OD14LkiwNFc6KM7:TR?=MVHTRW5ITVJ?
A498NFjUVGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\LbnBKSzVyPU[uPFE6PjFizszNNU[yenh2W0GQR1XS
TE-12NFnpV5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTZwOEO4NVch|ryPMmjVV2FPT0WU
TE-6M2TOUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIe5b3FKSzVyPU[uPVMxOzhizszNM3TwSnNCVkeHUh?=
AU565NXfoUGhET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnnrTWM2OD14Lkm2PVU4KM7:TR?=MnvrV2FPT0WU
RDM3LldWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYrJR|UxRTZwOUiyPFQh|ryPMnfvV2FPT0WU
SW1463MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml32TWM2OD15LkGxNVY5KM7:TR?=MojKV2FPT0WU
LU-99AMlyyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3:wbWlEPTB;Nz6xOFMzOiEQvF2=NXL1VnFKW0GQR1XS
NCI-H28M4\qT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEjuWWFKSzVyPUeuNlkzPCEQvF2=NWrJd4d1W0GQR1XS
MC-IXCM33SN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILQXG9KSzVyPUeuOFg2PzZizszNNU\oNoNyW0GQR1XS
GP5dNGDxXGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;ETWM2OD15LkS4O|Y1KM7:TR?=M1PaNnNCVkeHUh?=
GB-1NVnHVnNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NET6TXNKSzVyPUeuOVQ5ODRizszNNXjF[WJDW0GQR1XS
CAL-33MoDmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvzZohKSzVyPUeuOlYzOzNizszNMmDYV2FPT0WU
MSTO-211HNYTIS|F[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTdwNkezN|Yh|ryPNXKxSoVwW0GQR1XS
TE-5MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4mx[mlEPTB;Nz63PVM{PCEQvF2=M1jYcnNCVkeHUh?=
D-566MGMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzuVVdHUUN3ME24MlA1PDJ7IN88US=>NGDoV5VUSU6JRWK=
JVM-3NH\sXmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVG3fVlKUUN3ME24MlE2OjZ6IN88US=>NFHMWZZUSU6JRWK=
T98GNWjYRZBOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTGTWM2OD16LkG4NFY4KM7:TR?=M3rEWXNCVkeHUh?=
HCC1954NGnTWJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3jcmpKSzVyPUiuOFUyODRizszNMXfTRW5ITVJ?
SF126MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvlTWM2OD16LkS1PVM3KM7:TR?=M{HDPHNCVkeHUh?=
LB996-RCCNUGyWoV3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVrsVFRSUUN3ME24MlU{OjV5IN88US=>MUHTRW5ITVJ?
SKG-IIIaMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX;CTHM2UUN3ME24MlY{ODZ7IN88US=>M{C3UXNCVkeHUh?=
NCI-SNU-1Mki1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRThwNkS2OFMh|ryPNXPleFBKW0GQR1XS
LB771-HNCMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXncmJNUUN3ME24MlY1Pjl4IN88US=>MoDMV2FPT0WU
SCC-4NIHJUVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHWTWM2OD16Lk[4NlE6KM7:TR?=M2CybnNCVkeHUh?=
CAMA-1NXnxe5oyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHvjfndKSzVyPUiuO|cyPDZizszNM2naenNCVkeHUh?=
D-502MGM2DjN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PoemlEPTB;OD63PFYzQSEQvF2=NFHlb3ZUSU6JRWK=
ESS-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRThwOEi3NFQh|ryPMXjTRW5ITVJ?
HEC-1NV25cYpVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TZWGlEPTB;OD64PVg3PiEQvF2=MXXTRW5ITVJ?
NB10MoTVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\6TWM2OD17LkCyNlI1KM7:TR?=MXfTRW5ITVJ?
8505CNHfzO2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\4TWM2OD17LkC0NlMzKM7:TR?=NG\1NYpUSU6JRWK=
EFO-27MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTlwMU[0NVIh|ryPMVHTRW5ITVJ?
HNMmLwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTlwMU[2Nlgh|ryPMnjwV2FPT0WU
DSH1MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzQV45xUUN3ME25MlIxQDdizszNMXnTRW5ITVJ?
NBsusSRNIjSOXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{\MZmlEPTB;OT6yO|QxOiEQvF2=M3L6R3NCVkeHUh?=
LS-123MlvkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTlwM{G3OlEh|ryPMUnTRW5ITVJ?
SHP-77MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlj2TWM2OD17LkO5PVM2KM7:TR?=MUHTRW5ITVJ?
ACNNIHVcFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTlwNUOyO|ch|ryPMVnTRW5ITVJ?
U251MmrLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTlwNkW1OFQh|ryPNFPoNIVUSU6JRWK=
A431NFXUSIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUXNdIE6UUN3ME25MlgxOjN6IN88US=>MnTYV2FPT0WU
5637NGfT[I5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTlwOES5PFQh|ryPNVSycVliW0GQR1XS
MDA-MB-157NHG1dXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MojETWM2OD17LkmyPFc5KM7:TR?=NELMVZNUSU6JRWK=
A101DMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGO2[4VKSzVyPUmuPVk6PzRizszNNEHuTWhUSU6JRWK=
YKG-1Ml25S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTFyLkKwNFYh|ryPMoDCV2FPT0WU
LAN-6NXHzTWVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPiXYZKSzVyPUGwMlIyPjRizszNMlrEV2FPT0WU
OVCAR-5NUDjVmhqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTxU4h5UUN3ME2xNE4zPDN|IN88US=>MmPTV2FPT0WU
A549NH\6dYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrDZ5htUUN3ME2xNE4{QTd|IN88US=>NU[zNWZnW0GQR1XS
no-11NUjGc3dWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGXjUIVKSzVyPUGwMlQ{PTNizszNNGrWVW1USU6JRWK=
SF539NXH4d4JPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4[5cGlEPTB;MUCuPVA1OSEQvF2=MnPHV2FPT0WU
A388MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XpXmlEPTB;MUGuN|g6PyEQvF2=M3TUdHNCVkeHUh?=
DELMonhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1mzO2lEPTB;MUGuOFI1KM7:TR?=Mo\qV2FPT0WU
SW954MkHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILtbXlKSzVyPUGxMlQ3PjhizszNNHW0cFhUSU6JRWK=
TK10MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHBTWM2OD1zMT61NlcyKM7:TR?=Mk\1V2FPT0WU
SW756M1jFZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGi0OVJKSzVyPUGxMlUzQTRizszNNVzpXY5oW0GQR1XS
PC-3M3TNN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTFzLkW3OlQh|ryPMXPTRW5ITVJ?
ONS-76MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3PhPWlEPTB;MUGuOlM3KM7:TR?=M3zYN3NCVkeHUh?=
A427NF\pOVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NETqOIxKSzVyPUGxMlcxQTNizszNNGXlTYhUSU6JRWK=
MEG-01M13Ebmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{HwTGlEPTB;MUGuO|UxQSEQvF2=NHXPW|hUSU6JRWK=
BB30-HNCM3jLNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYjTO3lsUUN3ME2xNU44QTh{IN88US=>NWHUPXNtW0GQR1XS
NCI-H1299M37qXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1TVVWlEPTB;MUGuPFA6OyEQvF2=MYHTRW5ITVJ?
GCTM3mzV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHTXdmRKSzVyPUGxMlgzOjhizszNM4XD[3NCVkeHUh?=
D-247MGNHzCU5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\JfVBKSzVyPUGxMlk3PjNizszNNYrvVWJPW0GQR1XS
CFPAC-1Mk\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXXJR|UxRTFzLkm3PFIh|ryPMn7GV2FPT0WU
EKVXMoLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFX1ZXZKSzVyPUGyMlA{OTNizszNMYfTRW5ITVJ?
CAL-51MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlOwTWM2OD1zMj6wO|E3KM7:TR?=NGLF[JBUSU6JRWK=
BB49-HNCNIDpS2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTF{LkGxO|ch|ryPNYTnXIpkW0GQR1XS
RPMI-7951MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHLK[2JKSzVyPUGyMlE5PTRizszNMWnTRW5ITVJ?
RH-1M1jOXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWixbJIzUUN3ME2xNk4zOTh2IN88US=>MYfTRW5ITVJ?
BCPAPMoDnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7JXoR6UUN3ME2xNk41PzR7IN88US=>MVvTRW5ITVJ?
GCIYNG\rNWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTF{LkWyNFkh|ryPM3XGVXNCVkeHUh?=
KNS-81-FDNVHPV4dFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGDa[3BKSzVyPUGyMlU5PjlizszNMV;TRW5ITVJ?
KYSE-140NGLOU4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYe2R3pEUUN3ME2xNk45PTl3IN88US=>MYfTRW5ITVJ?
Ca-SkiM1PYZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTF{LkmwOFEh|ryPMVjTRW5ITVJ?
TGBC1TKBMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MofITWM2OD1zMj65NVE2KM7:TR?=NYHIbItIW0GQR1XS
HCC1187M{XvOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYP5fXZvUUN3ME2xN{4yQTF{IN88US=>M3G3OnNCVkeHUh?=
SJSA-1MlzoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4K1ZmlEPTB;MUOuNlMzPyEQvF2=NXTDZ5pLW0GQR1XS
CTV-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn3KTWM2OD1zMz6zOFUh|ryPM{LlSXNCVkeHUh?=
WM-115MoPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\PXmI6UUN3ME2xN{43PDh|IN88US=>NF;k[FlUSU6JRWK=
CHP-212MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTF|Lkm3N|kh|ryPNWPXRYpvW0GQR1XS
SCC-15MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NW\URY1PUUN3ME2xN{46Pzd3IN88US=>MXPTRW5ITVJ?
BPH-1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWjNcXNyUUN3ME2xOE4yPjZ2IN88US=>M2\nbnNCVkeHUh?=
SW780M4Hxc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HJdGlEPTB;MUSuOVAzPSEQvF2=M3u5UnNCVkeHUh?=
NCI-H2291MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTF2LkW4O|gh|ryPM1O1XnNCVkeHUh?=
JEG-3MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmrNTWM2OD1zND62N|I3KM7:TR?=M2fVWnNCVkeHUh?=
CAL-120NFq4TXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFjjN3dKSzVyPUG0MlcxOjdizszNNUK4So9WW0GQR1XS
NCI-H23NGDLdFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWfrXGxtUUN3ME2xOE44QTl5IN88US=>MoDEV2FPT0WU
MS-1Mk\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIjNfI5KSzVyPUG0Mlk3OTFizszNM3TRbHNCVkeHUh?=
PC-14M{X1PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWPlSnp5UUN3ME2xOE46PjV2IN88US=>MnLWV2FPT0WU
D-283MEDMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnfBTWM2OD1zNT6wNVEyKM7:TR?=NH;PXpFUSU6JRWK=
OE19NH:2fWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXXxVJJEUUN3ME2xOU4yPTRzIN88US=>MoHHV2FPT0WU
CAS-1M{TBSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWLJR|UxRTF3LkSxPFQh|ryPMXfTRW5ITVJ?
NCI-H727NFnve3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFL2OGRKSzVyPUG1MlQzOjFizszNNXKxUpNYW0GQR1XS
SiHaMmW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWrJR|UxRTF3Lke1PVQh|ryPNWnDZmhTW0GQR1XS
BFTC-905MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2jnSmlEPTB;MUWuO|Y6PCEQvF2=M4nTcXNCVkeHUh?=
MDA-MB-453MlTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTF4LkG2OFIh|ryPM{X2dnNCVkeHUh?=
HuP-T3MnzYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHmyVVRKSzVyPUG2MlY{PzNizszNNIXZUW9USU6JRWK=
SK-LU-1M1n0O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYiwSZVCUUN3ME2xOk43QTV4IN88US=>NY\tVZdxW0GQR1XS
Detroit562MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUXX[25LUUN3ME2xOk44OzF6IN88US=>NHHLR2hUSU6JRWK=
HCC1569NXXCR41PT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{fOTmlEPTB;MU[uPFM{PyEQvF2=NV3jXmZ6W0GQR1XS
SK-MES-1NGjueZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fudWlEPTB;MU[uPFQyQSEQvF2=MmLJV2FPT0WU
BB65-RCCMmnyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoTYTWM2OD1zNz6wOFc6KM7:TR?=MXXTRW5ITVJ?
LOXIMVINH3OflNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDCTWM2OD1zNz6wO|A4KM7:TR?=NVzofZA2W0GQR1XS
SW1783M{G3T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jyPGlEPTB;MUeuNVI5KM7:TR?=M3z6VnNCVkeHUh?=
NH-12NXzkU3k5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{GweGlEPTB;MUeuN|MxOyEQvF2=NVva[HREW0GQR1XS
UACC-257NF6zTWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\RTWM2OD1zNz61OVEzKM7:TR?=NUnRWIR{W0GQR1XS
KOSC-2MkfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPBXJIyUUN3ME2xO{43PzV5IN88US=>NEX3enNUSU6JRWK=
KG-1NXPnNYF6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzxTWM2OD1zNz62PVM4KM7:TR?=MlXXV2FPT0WU
M059JM3u0eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTF5LkewN{DPxE1?M3e3Z3NCVkeHUh?=
MHH-NB-11NH;PeZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVH1PHhSUUN3ME2xO{46Pjd|IN88US=>MUPTRW5ITVJ?
EW-1MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHLZNVlKSzVyPUG4MlE{QDJizszNM2XNXXNCVkeHUh?=
CAL-85-1MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXCUFNKSzVyPUG4MlI{PTdizszNMorSV2FPT0WU
639-VMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVfUbnA1UUN3ME2xPE4{OzV2IN88US=>NHzYcoRUSU6JRWK=
C32M{jENmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUS0clZLUUN3ME2xPE41PzJ5IN88US=>M3fJSnNCVkeHUh?=
KM-H2NIe1U5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LzNmlEPTB;MUiuOVI{OiEQvF2=NIL1U4pUSU6JRWK=
A253NFHmd|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWfJR|UxRTF6LkeyPFYh|ryPNYXWNYlbW0GQR1XS
NCI-N87NVTMdlhvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnvTmpkUUN3ME2xPE46ODB6IN88US=>MXXTRW5ITVJ?
8-MG-BAMmT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTXTWM2OD1zOT6wOlQ3KM7:TR?=Mn21V2FPT0WU
GI-ME-NNI\s[3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFTH[WxKSzVyPUG5MlE2PDZizszNNH\aeVlUSU6JRWK=
8305CMmW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYrJR|UxRTF7LkKyPFYh|ryPMUPTRW5ITVJ?
TE-8MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWjJR|UxRTF7LkOwNlQh|ryPMXnTRW5ITVJ?
KYSE-270M{nOcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTJyLkCyNVch|ryPM1zCfXNCVkeHUh?=
HL-60NX\OS4U6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFH3V2xKSzVyPUKwMlA6PDFizszNM{HzTHNCVkeHUh?=
Mo-TMk\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVT4OngxUUN3ME2yNE4yPjZ3IN88US=>NHeweItUSU6JRWK=
NCI-H1355NVz2SnVqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmD6TWM2OD1{MD6zN|c1KM7:TR?=NVXHbYQyW0GQR1XS
HT-1080MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml3FTWM2OD1{MD61OFk4KM7:TR?=MVvTRW5ITVJ?
MIA-PaCa-2NHz2WVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVG3WIxLUUN3ME2yNE43QDh|IN88US=>M3jmcnNCVkeHUh?=
NCI-H441NFK1[oNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLmbmF7UUN3ME2yNE44Ozd7IN88US=>MojlV2FPT0WU
LCLC-97TM1M1LZfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTJyLkixN|Qh|ryPM{Pl[XNCVkeHUh?=
HT-3NXTSNWJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTJzLkW2N|Eh|ryPNVfZfpVXW0GQR1XS
22RV1NXrlWlZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF3oZpJKSzVyPUKxMlU3QDVizszNMn:xV2FPT0WU
LK-2M3;aeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3JdG5zUUN3ME2yNU42QTV|IN88US=>M4XHVXNCVkeHUh?=
CW-2M3LORmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTJzLk[wOlkh|ryPNXLQ[ZpMW0GQR1XS
KYSE-510MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTJzLk[wPVUh|ryPM13lcnNCVkeHUh?=
CGTH-W-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYP5fWhyUUN3ME2yNU44OTZ4IN88US=>NInEeXpUSU6JRWK=
NCI-H661MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTJ{LkCzOEDPxE1?NWjoR3dHW0GQR1XS
KU-19-19M2XnWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIW1WYpKSzVyPUKyMlE3QTdizszNM1X5UHNCVkeHUh?=
NCI-H2122MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF[0OWhKSzVyPUKyMlI1OzJizszNNHHiSodUSU6JRWK=
NCI-H526M3;HR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mmm4TWM2OD1{Mj6zPFk2KM7:TR?=M{DafXNCVkeHUh?=
NCI-H1650NIHOZmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDpcJdHUUN3ME2yNk44PjRizszNMnHHV2FPT0WU
AM-38MmjrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYHJR|UxRTJ{Lki2PFkh|ryPMmLSV2FPT0WU
NCI-H2405NWC3cIZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3n5RmlEPTB;MkOuNlU{OyEQvF2=NHHaSnRUSU6JRWK=
M14NGe2[2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGrOSI9KSzVyPUKzMlQxQDhizszNM1XxcnNCVkeHUh?=
ES4MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrNPHhKSzVyPUKzMlQzOzJizszNNYXzZmZvW0GQR1XS
DJM-1NHjafYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Moe3TWM2OD1{Mz61NlM1KM7:TR?=MXvTRW5ITVJ?
S-117NIToVoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTRTWM2OD1{Mz63OlUyKM7:TR?=NXzQ[4MzW0GQR1XS
MZ2-MELMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETRcZdKSzVyPUKzMlc4PTlizszNNFnIVVlUSU6JRWK=
SK-MEL-2MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzDSVFKSzVyPUKzMlgyOzNizszNMl3aV2FPT0WU
HCC1806MoTBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTJ|Lki3NFkh|ryPNXr4WJRqW0GQR1XS
NMC-G1NGm1d4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXrYSWVRUUN3ME2yOE4zOjJ4IN88US=>NYDieWZEW0GQR1XS
DK-MGMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV\QPGl6UUN3ME2yOE4zQTRizszNMX;TRW5ITVJ?
SK-N-FIM3z1R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjZSVZKSzVyPUK0MlM{ODJizszNMmLrV2FPT0WU
KINGS-1MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTxc3htUUN3ME2yOE41QDd2IN88US=>MnjVV2FPT0WU
HCC2998Moi2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoexTWM2OD1{ND60PFg2KM7:TR?=MVzTRW5ITVJ?
ALL-POMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEfre2VKSzVyPUK0MlYyQSEQvF2=MoT3V2FPT0WU
MPP-89NVrtUo9[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGfWfplKSzVyPUK1MlA1PThizszNMmP0V2FPT0WU
NCI-H2342M4njPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEW4dpVKSzVyPUK1MlE6PTNizszNM13BZ3NCVkeHUh?=
TE-1NUS0OZU3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfJ[4VKSzVyPUK1MlM2PjNizszNMlPwV2FPT0WU
RH-18MlHFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH\hR25KSzVyPUK1MlU6OThizszNMX;TRW5ITVJ?
HT-1376NFj0SIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nwcmlEPTB;MkWuOlQ3PSEQvF2=NFj1XGVUSU6JRWK=
U-2-OSNYS2RmczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULiW4wyUUN3ME2yOU43QDh6IN88US=>MVLTRW5ITVJ?
BT-549NX3UV3hzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTJ3LkmwNVEh|ryPM3XlbHNCVkeHUh?=
NCI-H1755Mlv3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXjzW5J7UUN3ME2yOU46QTR3IN88US=>M1\IfHNCVkeHUh?=
EW-13NXrHRmo4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XGTmlEPTB;Mk[uNFI4PCEQvF2=MUnTRW5ITVJ?
NB13NXXkZ|dzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXUTWM2OD1{Nj6wPVQ6KM7:TR?=M3TjNHNCVkeHUh?=
NUGC-3MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXnWm1YUUN3ME2yOk4zOTB|IN88US=>NWTDO5U3W0GQR1XS
GMS-10NITWe2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\QTWM2OD1{Nj6yN|U{KM7:TR?=MXjTRW5ITVJ?
CHP-134NX3SSVluT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13tNWlEPTB;Mk[uN|g3PyEQvF2=NGTYWGRUSU6JRWK=
SW962MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzqc4dyUUN3ME2yOk42ODJzIN88US=>NVG0[GljW0GQR1XS
SNU-449NHHlWJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTJ5LkC4NFMh|ryPNX30d|BVW0GQR1XS
HuP-T4Mlj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3ziSGlEPTB;MkeuNFg4QSEQvF2=MlPmV2FPT0WU
SW948MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnubWdKSzVyPUK3MlE{PDRizszNMX7TRW5ITVJ?
NCI-H226MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITWOIZKSzVyPUK3MlQ2PzhizszNNVO5ZXY6W0GQR1XS
SK-PN-DWNEnGfJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGr6dphKSzVyPUK3MlYxOTJizszNM2Tvc3NCVkeHUh?=
GI-1M4rKO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTJ5LkeyNUDPxE1?NYXrRW9OW0GQR1XS
CAL-12TNULOSIhET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33h[2lEPTB;MkiuNVEyOiEQvF2=MXLTRW5ITVJ?
YAPCMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVvJR|UxRTJ6LkK1OlQh|ryPNWTkR3B7W0GQR1XS
SNU-C2BM{TuZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vCUWlEPTB;MkiuNlk3PCEQvF2=MnqxV2FPT0WU
RCC10RGBMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHxTWM2OD1{OD61OFE4KM7:TR?=MVLTRW5ITVJ?
ES7MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmSxTWM2OD1{OT6xOFY2KM7:TR?=M1LJeXNCVkeHUh?=
PANC-03-27MlTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUTNVIZEUUN3ME2yPU41PDRizszNMoGxV2FPT0WU
ES6MnPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7JcZVKSzVyPUK5MlgyPTdizszNNFrG[GZUSU6JRWK=
HT-1197NV\Yc2tlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\TTWM2OD1|MD6wOVk5KM7:TR?=MoD2V2FPT0WU
ZR-75-30MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\iNGlEPTB;M{CuNlM5OyEQvF2=NYjId2diW0GQR1XS
DBMkDaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\nTWM2OD1|MD60PVQzKM7:TR?=M4DMZ3NCVkeHUh?=
OCI-AML2NUXidpVET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXMTWM2OD1|MT6wOlkh|ryPNGjGUmdUSU6JRWK=
NCI-H2170MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XHd2lEPTB;M{GuPFUyPiEQvF2=MmPlV2FPT0WU
IST-MES1M{HKWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nqTmlEPTB;M{KuNlg6PyEQvF2=MmPmV2FPT0WU
769-PMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTN{LkO2OFEh|ryPMWrTRW5ITVJ?
COR-L23NUe1NIN7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MorxTWM2OD1|Mj65NFc{KM7:TR?=Mm\MV2FPT0WU
SW626M{HpPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnLJTWM2OD1|Mz6xO|c3KM7:TR?=Ml[yV2FPT0WU
LU-139MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPITWM2OD1|Mz62OlA2KM7:TR?=NVrPSYVnW0GQR1XS
HT-144NHHsTFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnuwTWM2OD1|Mz64OlMh|ryPMnH6V2FPT0WU
CaR-1NF22[Y9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIrJWIVKSzVyPUOzMlk5OjJizszNMmS2V2FPT0WU
OE33MoHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTN2LkK4OVUh|ryPMYfTRW5ITVJ?
COLO-800NGfYbpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHTTWM2OD1|ND6zOlQ4KM7:TR?=MUnTRW5ITVJ?
NB14NV;YR4ZWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTN2LkS2PFQh|ryPM2TmUnNCVkeHUh?=
KURAMOCHIM2TvUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M322bGlEPTB;M{[uNVE6QCEQvF2=MUjTRW5ITVJ?
SW48M3qyOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV6zSY9RUUN3ME2zOk4zPDd2IN88US=>MWLTRW5ITVJ?
DaoyMnm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\0TWM2OD1|Nj62OVM5KM7:TR?=NW\5VmNGW0GQR1XS
TGBC24TKBNU\DR3k2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmrRTWM2OD1|Nj62O{DPxE1?NH\QWJVUSU6JRWK=
DU-4475NVjCOXpLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTN4LkmwN|Mh|ryPM1vPWXNCVkeHUh?=
SW1417NYm0No5kT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HqO2lEPTB;M{iuNFU2OiEQvF2=MUPTRW5ITVJ?
EFO-21M3f4Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXfJR|UxRTN6LkmzOFkh|ryPMlf2V2FPT0WU
MG-63MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXGTWM2OD1|OT6zOFI1KM7:TR?=MkjPV2FPT0WU
LC-2-adNFLIfI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzRV5RKSzVyPUO5MlU2OTJizszNMn24V2FPT0WU
NOMO-1Mn3QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYTtSnVFUUN3ME2zPU45Ojd2IN88US=>M17QN3NCVkeHUh?=
COLO-741M4SxS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTRyLkGzNFQh|ryPMlLMV2FPT0WU
BxPC-3NIjtXmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnH3TWM2OD12MD61Olg3KM7:TR?=MVrTRW5ITVJ?
HSC-2MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGixZpVKSzVyPUSwMlkyOTNizszNNInUOmNUSU6JRWK=
UMC-11MoTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrvTWM2OD12MT6yOlMh|ryPMYXTRW5ITVJ?
HCC1937Mm[1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;yeoNKSzVyPUSyMlc5PDNizszNNFTXVXhUSU6JRWK=
Calu-6NGHvOWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnnN4xZUUN3ME20N{4zOzh{IN88US=>M37uTnNCVkeHUh?=
NCI-H1573M{nD[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTR|LkO0O|ch|ryPMYjTRW5ITVJ?
SK-N-ASNEDkdIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jlNGlEPTB;NEOuOlAyQSEQvF2=NV\QWGw{W0GQR1XS
PSN1MlO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmGyTWM2OD12NT6yOVQ5KM7:TR?=MkHmV2FPT0WU
TE-11NFfwPXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2jkVmlEPTB;NEWuOFg1OiEQvF2=NEjuU21USU6JRWK=
NCI-H1155MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGDxfHdKSzVyPUS1Mlg6PjdizszNM2G0b3NCVkeHUh?=
KM12NWjYPZZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTR3LkmwO|Yh|ryPNXfDc2I6W0GQR1XS
RO82-W-1M2nDRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWPJR|UxRTR4Lkm4NlIh|ryPNWj5O3cxW0GQR1XS
SW1573M3nSZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrYTWM2OD12Nz6zO|M3KM7:TR?=MVnTRW5ITVJ?
CAKI-1MmnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHTSmkxUUN3ME20PE4zQDR3IN88US=>NVTjPGVKW0GQR1XS
U-118-MGMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XOOmlEPTB;NEiuN|cxOiEQvF2=NUDtflVEW0GQR1XS
KYSE-520M3\Qdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF[zXYNKSzVyPUS4MlQxOTZizszNNXvoRnlxW0GQR1XS
HT55MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTR7LkG0O|Qh|ryPMXnTRW5ITVJ?
ChaGo-K-1NEX5c5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{PVeWlEPTB;NEmuOFc6OyEQvF2=NI[1R3VUSU6JRWK=
IA-LMMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF7uUYlKSzVyPUW0MlY{OjJizszNNX\R[nl[W0GQR1XS
UACC-62MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\nXVVjUUN3ME21OU4yODR4IN88US=>MY\TRW5ITVJ?
MKN7MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV7JR|UxRTV4LkCyPFUh|ryPM3yyeHNCVkeHUh?=
HPAF-IIM{fHfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojXTWM2OD13Nj60NFc{KM7:TR?=NWTxO2tbW0GQR1XS
NTERA-S-cl-D1NHr4enpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVP0O|dnUUN3ME21O{44PzhizszNNX7INWkxW0GQR1XS
FTC-133NVThclAzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\KS|NKSzVyPUW4MlA6PjlizszNNUfCSYZ1W0GQR1XS
MHH-ES-1NVvzNWQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTXTWM2OD13OD60PFE1KM7:TR?=NUP0R4Z1W0GQR1XS
JVM-2NGezenhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3v0VWlEPTB;NUiuPVUxPiEQvF2=MYfTRW5ITVJ?
TCCSUPMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTV7LkWyO|kh|ryPMWLTRW5ITVJ?
COLO-824MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYj1XWU5UUN3ME22NE4xPzF7IN88US=>Mn7YV2FPT0WU
647-VM2\YbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUK5UVVMUUN3ME22NE4yOzR5IN88US=>NFXpXIVUSU6JRWK=
HD-MY-ZMX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1n5UGlEPTB;NkCuOVI6PCEQvF2=Ml3qV2FPT0WU
LS-411NNI\DboJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mom2TWM2OD14MT6zPVA{KM7:TR?=M3nJSHNCVkeHUh?=
NCI-H596M1fNWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfCXmRKSzVyPU[yMlc1QTZizszNNXPnemJNW0GQR1XS
C-33-AM3zZe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nvOmlEPTB;NkSuNFk2PyEQvF2=MoT4V2FPT0WU
BHYNXXMcIVnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmS1TWM2OD14ND6xNlQ2KM7:TR?=M{jD[XNCVkeHUh?=
KGNNVzkVlVkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnkdVdKSzVyPU[0MlU2OTRizszNMVjTRW5ITVJ?
NCI-H1092MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX3JR|UxRTZ3LkCwPVUh|ryPMV3TRW5ITVJ?
MZ1-PCMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTZ3LkW2OFkh|ryPNWDlSm5VW0GQR1XS
LB831-BLCNEjoW4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvTTWM2OD14NT64OFgyKM7:TR?=MkKyV2FPT0WU
SW620NG\4PIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkC1TWM2OD14Nj6yNFM6KM7:TR?=MYfTRW5ITVJ?
HuO-3N1MnvvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NULtT2Y3UUN3ME22PE4{OjN6IN88US=>MVvTRW5ITVJ?
SK-HEP-1M1vkXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFLPOJRKSzVyPU[5Mlk1QDZizszNMmXCV2FPT0WU
LCLC-103HM{[4Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPzNI5MUUN3ME23NE43PzB3IN88US=>NX7neYZEW0GQR1XS
KYSE-70MknnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTdyLke4N|Uh|ryPNYXaRnNjW0GQR1XS
MewoM4\Kcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLEOFRUUUN3ME23NU42ODVizszNNXv3RWVWW0GQR1XS
COLO-668MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4LPNGlEPTB;N{GuPFQ2OSEQvF2=Mn3QV2FPT0WU
NCI-H522MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3LGW2lEPTB;N{KuN|QyOyEQvF2=MonYV2FPT0WU
NCI-H1437NVG3NW1WT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPzPXJKSzVyPUe0MlQxPDhizszNMU\TRW5ITVJ?
U-266MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGGzVmhKSzVyPUe1MlQ2OTZizszNNUXs[lU5W0GQR1XS
MC116M1j5dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTd3LkW3NFgh|ryPMWrTRW5ITVJ?
PANC-10-05MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoX3TWM2OD15Nz60NlQ{KM7:TR?=M1W2fXNCVkeHUh?=
KYSE-180MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2DtdWlEPTB;N{euOVQ2PCEQvF2=MkXGV2FPT0WU
JARMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPSPZpCUUN3ME23PU4xPTR4IN88US=>NX\3OJhRW0GQR1XS
CAL-62Mn74S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2TnUmlEPTB;OECuNFk2KM7:TR?=NEW0N|hUSU6JRWK=
A3-KAWNGLE[HZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULHWYVJUUN3ME24NE4zOTV2IN88US=>NUHQNm11W0GQR1XS
PANC-08-13Mn3SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVf3fmlxUUN3ME24NU4yPzZ6IN88US=>MknmV2FPT0WU
HSC-3M2\OOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYPRflVxUUN3ME24N{4{ODdzIN88US=>NHLjdmlUSU6JRWK=
HTC-C3MmDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWOxV4tsUUN3ME24N{41PzB{IN88US=>NXfJbYF3W0GQR1XS
KY821NFq4O4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHu4[VNKSzVyPUi0MlA5QTJizszNNF3vWoxUSU6JRWK=
DoTc2-4510NUK2fpA1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXLJR|UxRTh2LkKxPFUh|ryPMV7TRW5ITVJ?
NCI-H1581NIPpSHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7tUllKSzVyPUi1MlQ3PDFizszNM{flOXNCVkeHUh?=
KARPAS-299M1zmVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTh4LkG5O|ch|ryPNHSyS4dUSU6JRWK=
IST-MEL1NXmxc|VKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2rhVmlEPTB;OE[uPFg4OiEQvF2=MXTTRW5ITVJ?
KP-N-YSMlnOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTh7LkmwNlgh|ryPMWjTRW5ITVJ?
KYSE-410NUHWNG9ET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHWTWM2OD17MT60NFQzKM7:TR?=M4joNnNCVkeHUh?=
TE-10NGLJUZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlLlTWM2OD17MT61OlEyKM7:TR?=NWq1clZkW0GQR1XS
SK-MEL-1MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjCN2dKSzVyPUmyMlkyODZizszNNUXNd4xjW0GQR1XS
COLO-792MkH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPJVotKSzVyPUm1MlI2PjRizszNMWHTRW5ITVJ?
SCHMofzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXvCSZd2UUN3ME25Ok4{QDd5IN88US=>NHXFN5JUSU6JRWK=
NCI-H1792NHXqRXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1jlO2lEPTB;OU[uPFk6OiEQvF2=Mk\kV2FPT0WU
NCI-H2029Mle4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3j5bWlEPTB;OU[uPVU3PiEQvF2=NGXxNpBUSU6JRWK=
SW684M3mwRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoTITWM2OD17OD62OlU1KM7:TR?=M2qySnNCVkeHUh?=
NCI-H209NFW2S4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTFyMD6xNlEh|ryPMVnTRW5ITVJ?
HLENVriTYQ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPJTWM2OD1zMEWuNlgzKM7:TR?=NVz6[XlDW0GQR1XS
GOTOMoPtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7ETWM2OD1zMEeuO|c4KM7:TR?=MnHCV2FPT0WU
NCI-H1793NGTLNmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\VUolKSzVyPUGwPU4zQCEQvF2=MoHSV2FPT0WU
D-392MGNFXnbZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlq2TWM2OD1zMUeuN|k5KM7:TR?=MlP3V2FPT0WU
SW1990M4\RZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\lTWM2OD1zMkCuPVUyKM7:TR?=NHrKVItUSU6JRWK=
ML-2MlnFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnLSTWM2OD1zMkGuOlc3KM7:TR?=MYDTRW5ITVJ?
NCI-H2452MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIrCXnJKSzVyPUGyNk4zOSEQvF2=NInIOo9USU6JRWK=
SK-MEL-30NWPWRXlGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrGTWM2OD1zMkOuNlQ1KM7:TR?=NH7DXZRUSU6JRWK=
SN12CMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWHCcYdOUUN3ME2xNlQvOTd4IN88US=>M3e4[HNCVkeHUh?=
NCI-H1770M{T1fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXH3NYZtUUN3ME2xNlUvPTF2IN88US=>MXnTRW5ITVJ?
SF268NVXpfJB7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4q0bGlEPTB;MUK2MlE2QCEQvF2=NWPKdoRkW0GQR1XS
BALL-1Mn\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWPJR|UxRTF{Nj6yN{DPxE1?MlrwV2FPT0WU
COLO-679M3zvUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4nPd2lEPTB;MUK2Mlc2OyEQvF2=NGrleWVUSU6JRWK=
A2780MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTF{OD65PFgh|ryPMnmyV2FPT0WU
NCI-H1651NE\zUZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHQTWM2OD1zM{GuNlQ{KM7:TR?=MlfBV2FPT0WU
NCI-H2087MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1OzWGlEPTB;MUOxMlQ5OyEQvF2=NIjuWFZUSU6JRWK=
U-87-MGNVPlWnJ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjQRod6UUN3ME2xN|MvPjB2IN88US=>NXzOcXVJW0GQR1XS
LB2518-MELNH3KdXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUm2SY5SUUN3ME2xN|UvQTl|IN88US=>M2Pze3NCVkeHUh?=
HCT-116MoLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzyTnFKSzVyPUGzO{4zOTdizszNNFX2TJlUSU6JRWK=
Ca9-22MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1La[mlEPTB;MUO5Mlg{OyEQvF2=M{L6NHNCVkeHUh?=
COR-L88MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2Dq[GlEPTB;MUSyMlE1KM7:TR?=M1LsR3NCVkeHUh?=
CP50-MEL-BNYjofZFZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmC4TWM2OD1zNESuOVAyKM7:TR?=NInocI5USU6JRWK=
OVCAR-8NITaTVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV7JR|UxRTF2NT62N|Yh|ryPMk\yV2FPT0WU
SK-MEL-3M1PWTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2CxSmlEPTB;MUS3Mlg4QCEQvF2=MWXTRW5ITVJ?
GT3TKBMl7JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHzYNJlKSzVyPUG0PU46OjhizszNM2f5b3NCVkeHUh?=
KYSE-450M4D0dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\iSGlEPTB;MUWxMlU{QSEQvF2=NYD2V|lGW0GQR1XS
CAPAN-1MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4n3WGlEPTB;MUWzMlA3PCEQvF2=NFzpOGVUSU6JRWK=
BENMnr0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4W5VmlEPTB;MUWzMlkzQCEQvF2=M1\FdHNCVkeHUh?=
NCI-H1304MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYH4fHVVUUN3ME2xOVQvPjl2IN88US=>MV\TRW5ITVJ?
KU812NGj3bm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDaTFBmUUN3ME2xOVgvPjd2IN88US=>MYfTRW5ITVJ?
Capan-2MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlOyTWM2OD1zNkCuOVU{KM7:TR?=MkmzV2FPT0WU
A673NUDibIl{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTF4MT63NFUh|ryPMnK0V2FPT0WU
SASNHvtfGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFHZ[VNKSzVyPUG2Nk43PzhizszNMnTpV2FPT0WU
NYNH;hTItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3i5N2lEPTB;MU[1MlMyPCEQvF2=NF74RnNUSU6JRWK=
HCE-4MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{KwS2lEPTB;MU[2Mlg1PSEQvF2=MmT5V2FPT0WU
MDA-MB-231M375Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTF5Nz61NFMh|ryPNWi2Z5NXW0GQR1XS
no-10NYTpVGZ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{HPTGlEPTB;MUe4MlE{PCEQvF2=NFPWO2lUSU6JRWK=
MZ7-melNFu5PVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHrKfnZKSzVyPUG3PE41PjdizszNM3H0OHNCVkeHUh?=
NCI-H82MofSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHWZZRMUUN3ME2xPFAvOTZ3IN88US=>MWjTRW5ITVJ?
CAL-72M2rrfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTF6NT6wOVQh|ryPM4ezZnNCVkeHUh?=
NCI-SNU-5NWnQZ3pyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTF6Nj64OEDPxE1?MV7TRW5ITVJ?
OVCAR-4M2XCeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGXPfllKSzVyPUG4PE4{OzNizszNNYnsNHJ3W0GQR1XS
SCC-9MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTF7MTFOwG0>M4rCWHNCVkeHUh?=
KYSE-150NY\JZmpQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlu4TWM2OD1zOUGuPFg5KM7:TR?=NW\X[md3W0GQR1XS
HT-29MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXT5NpFXUUN3ME2yNFEvOjF{IN88US=>NFrQ[VlUSU6JRWK=
COLO-678MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPXTWM2OD1{MEGuOFUh|ryPNE\tVlhUSU6JRWK=
NCI-H650NGfIXnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnW0TWM2OD1{MEKuNVA{KM7:TR?=MUHTRW5ITVJ?
HuCCT1MlLYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\YWmlEPTB;MkC0MlIxQCEQvF2=MWXTRW5ITVJ?
SW1116MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGrOOW9KSzVyPUKwO{4xPzdizszNMn7DV2FPT0WU
DBTRG-05MGM2fEfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXXTWM2OD1{MEeuPVA6KM7:TR?=NYTtXHhmW0GQR1XS
SW982M4\YN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;r[nlKSzVyPUKwO{46PDhizszNMV\TRW5ITVJ?
RCM-1MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XWdGlEPTB;MkG0Mlc3OiEQvF2=NHv0OG1USU6JRWK=
COLO-320-HSRNXXMXmhZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3fubWlEPTB;MkG2MlEzPSEQvF2=Mm\DV2FPT0WU
KNS-42M1vpdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTJzNj61O|Qh|ryPNYXENWs6W0GQR1XS
C2BBe1NH7SPJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTJ|MT65NFUh|ryPM1PFbXNCVkeHUh?=
CCRF-CEMNHfQ[lFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV7DRXFNUUN3ME2yOFMvPzl3IN88US=>NXv0RolJW0GQR1XS
SH-4NX\CUJFbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEGxUI1KSzVyPUK0Ok4xQSEQvF2=NXfkZVZ6W0GQR1XS
LS-1034MnfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;ZOnBKSzVyPUK0Ok4zPjZizszNNILJXVZUSU6JRWK=
NCI-H2347MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{D6SWlEPTB;MkS3MlcyOyEQvF2=M3vm[nNCVkeHUh?=
RPMI-8866M{C3bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVu4XJJ7UUN3ME2yOFkvOjdizszNMU\TRW5ITVJ?
GAKMoT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnvTWM2OD1{NUOuNFAzKM7:TR?=NVzzWVh6W0GQR1XS
NB6Mmm5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTJ5MD6xJO69VQ>?MYXTRW5ITVJ?
COLO-680NNIHwXFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXxTWM2OD1{N{KuOVI4KM7:TR?=NXLub3RwW0GQR1XS
RERF-LC-MSMoj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1X3b2lEPTB;Mke2MlAxPyEQvF2=NWixe4Z3W0GQR1XS
TGBC11TKBNGr3cWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTJ5OD6xO|gh|ryPMonZV2FPT0WU
C8166NXHwbVZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3;DdmlEPTB;Mke4MlUxPiEQvF2=Ml\UV2FPT0WU
HDLM-2M3GzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\1O4RKSzVyPUK5OE41ODlizszNNF7EcHdUSU6JRWK=
IGR-1MnnyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX:xWmxTUUN3ME2yPVUvPjV7IN88US=>MkPDV2FPT0WU
FADUMnTlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWPte|NzUUN3ME2yPVcvPTFizszNMXrTRW5ITVJ?
L-428NXLUXGpRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mmf5TWM2OD1{OUeuOlE3KM7:TR?=MnrvV2FPT0WU
LU-65NH\RenVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXr3[lNVUUN3ME2zNFQvOzJizszNNYHIdmpHW0GQR1XS
HELNGfObnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HaNWlEPTB;M{C5Mlk5OyEQvF2=NXnkVIN3W0GQR1XS
NCI-H810Mkn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3COXJKSzVyPUOxNE42PyEQvF2=MoPRV2FPT0WU
C3ANU\scmhnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfsbJlKSzVyPUOxNU45ODJizszNNXz1[W86W0GQR1XS
NCI-H630NXzxZnFXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1m0e2lEPTB;M{OyMlI6PCEQvF2=M{\H[nNCVkeHUh?=
KP-N-YNMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfyT3VKSzVyPUO0NU4yOjNizszNNGH4e5JUSU6JRWK=
MOLT-13MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTN2Mj6zNlYh|ryPNGn4TnRUSU6JRWK=
NCI-H1993M4PoZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3HDOGlEPTB;M{SyMlM3PSEQvF2=MWXTRW5ITVJ?
BE-13MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2TaOWlEPTB;M{S0MlE3PyEQvF2=NUe3cm86W0GQR1XS
IST-SL1MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MontTWM2OD1|NEeuOFAyKM7:TR?=MmjtV2FPT0WU
TE-9NV;UOm1lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1SycGlEPTB;M{[zMlU5QSEQvF2=NIfVclRUSU6JRWK=
LU-135MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIj0WW5KSzVyPUO2O{4xOzVizszNMmHzV2FPT0WU
T84NGP5WJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV7JR|UxRTN5ND63NVIh|ryPNG\r[25USU6JRWK=
K-562NYS4cFgzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnGWWZTUUN3ME2zPFMvOzZizszNMVPTRW5ITVJ?
SBC-5MmLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHDTWM2OD1|OE[uPVg2KM7:TR?=MWLTRW5ITVJ?
NB17MmXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGLJWpdKSzVyPUO5Nk42QTZizszNMl3FV2FPT0WU
NCI-H2052NFPySYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPyTWM2OD1|OUiuOFczKM7:TR?=NFnrWG5USU6JRWK=
HCC38M4rkWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmnJTWM2OD12MEGuOVk{KM7:TR?=NH[xbVVUSU6JRWK=
NCI-H69MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPlWpJ1UUN3ME20OFEvODh|IN88US=>NGDhbI9USU6JRWK=

... Click to View More Cell Line Experimental Data

In vivo MK-2206 shows 60% TGI and inhibits more than 70 % of phospho-Akt1/2 (T308 and S473) in A2780 ovarian cancer xenografts at a dose of 240 mg/kg. [1] MK-2206 exhibits significant antitumor activity in NCI-H292 xenograft in combination with erlotinib or lapatinib. [2]
Features The first allosteric small molecule inhibitor of Akt to enter clinical development.

Protocol(Only for Reference)

Kinase Assay: [4]

Akt kinases assay Akt kinases are assayed by a GSK-derived biotinylated peptide substrate. The extent of peptide phosphorylation is determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide. When the Lance and APC are in proximity, a non-radiative energy transfer takes place from the Lance to the APC, followed by emission of light from APC at 655 nm. Working Solution: 100X protease inhibitor cocktail (PIC): 1mg/mL benzamidine, 0.5 mg/mL pepstatin, 0.5 mg/mL leupeptin, 0.5 mg/mL aprotinin; 10X assay buffer: 500 mM HEPES, pH7.5, 1% PEG, 16.6 mM EDTA, 1 mM EGTA, 1% BSA, 20 mM 9-glycerol phosphate; Quench buffer 50 mM HEPES pH 7.3, 16.6 mM EDTA, 0.1% BSA, 0.1% Triton X-100, 0.17 nM labeled monoclonal antibody, 0.0067 mg/mL SA-APC; ATP/MgCl2 working solution: 1X Assay buffer, 1 mM DTT, 1X PIC, 5% glycerol, active Akt; Peptide working solution: 1X Assay buffer, 1 mM DTT, 1X PIC, 5% glycerol, 2 TM GSK biotinylated peptide. The reaction is assembled by adding 16 µL of ATP/MgCl2 working solution to the appropriate wells. MK-2206 or vehicle (1.0 µL) is added followed by 10 µL of peptide working solution. The reaction is started by adding 13 μL of the enzyme working solution and mixing. The reaction is allowed to proceed for 50 min and then stopped by the addition of 60 µL HTRF quench buffer. The stopped reactions are incubated at room temperature for at least 30 min and then read in the instrument.

Cell Assay: [2]

Cell lines A431, HCC827, NCI-H292, NCI-H358, NCI-H23, NCI-H1299, Calu-6 and NCI-H460 cells
Concentrations 0, 0.3, 1 and 3 μM
Incubation Time 72 or 96 hours
Method MK-2206 is dissolved in DMSO as a stock solution and diluted by culture media before use. Cells are seeded at a density of 2-3 × 103 in 96-well plates and incubated for 24 hours. Then MK-2206 (0, 0.3, 1 and 3 μM) is added to the cells. Cell proliferation is determined after 72 or 96 hours.

Animal Study: [2]

Animal Models SK-OV-3, NCI-H292, HCC70, PC-3, and NCI-H460 models in male CD1-nude mice
Formulation Formulated in 30% Captisol
Dosages 120 mg/kg
Administration Orally administered

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Yan L, AACR Annual Meeting 2009: Abstract Number: DDT01-1.

[2] Hirai H, et al. Mol Cancer Therapy, 2010, 9(7), 1956-1967.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01802320 Active, not recruiting Colon Mucinous Adenocarcinoma|Colon Signet Ring Cell Adenocarcinoma|Rectal Mucinous Adenocarcinoma|Rectal Signet Ring Cell Adenocarcinoma|Recurrent  ...more Colon Mucinous Adenocarcinoma|Colon Signet Ring Cell Adenocarcinoma|Rectal Mucinous Adenocarcinoma|Rectal Signet Ring Cell Adenocarcinoma|Recurrent Colon Carcinoma|Recurrent Rectal Carcinoma|Stage IIIA Colon Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer National Cancer Institute (NCI) March 2013 Phase 2
NCT01783171 Recruiting Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic Carcinoma National Cancer Institute (NCI) January 2013 Phase 1
NCT01776008 Active, not recruiting Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|St  ...more Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer National Cancer Institute (NCI) January 2013 Phase 2
NCT01859182 Withdrawn Adenocarcinoma of the Gallbladder|Adenocarcinoma With Squamous Metaplasia of the Gallbladder|Adult Primary Cholangiocellular Carcinoma|Advanced Adu  ...more Adenocarcinoma of the Gallbladder|Adenocarcinoma With Squamous Metaplasia of the Gallbladder|Adult Primary Cholangiocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Localized Unresectable Adult Primary Liver Cancer|Metastatic Extrahepatic Bile Duct Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Stage II Gallbladder Cancer|Stage IIIA Gallbladder Cancer|Stage IIIB Gallbladder Cancer|Stage IVA Gallbladder Cancer|Stage IVB Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer National Cancer Institute (NCI) January 2013 Phase 2
NCT01705340 Terminated Adenocarcinoma of the Gastroesophageal Junction|HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Recurrent Esophageal Cancer|  ...more Adenocarcinoma of the Gastroesophageal Junction|HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Recurrent Esophageal Cancer|Recurrent Gastric Cancer|Stage IIIC Breast Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Gastric Cancer|Stage IV Breast Cancer|Stage IV Esophageal Cancer|Stage IV Gastric Cancer National Cancer Institute (NCI) September 2012 Phase 1

view more

Chemical Information

Download MK-2206 2HCl SDF
Molecular Weight (MW) 480.39
Formula

C25H21N5O.2HCl

CAS No. 1032350-13-2
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 14 mg/mL (29.14 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 15% Captisol 17 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Akt Products

  • Afuresertib (GSK2110183)

    Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.

  • AT13148

    AT13148 is an oral, ATP-competitive, multi-AGC kinase inhibitor with IC50 of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1.

  • SC79

    SC79 is a brain-penetrable Akt phosphorylation activator and an inhibitor of Akt-PH domain translocation.

  • AZD5363

    AZD5363 potently inhibits all isoforms of Akt(Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM in cell-free assays, similar to P70S6K/PKA and lower activity towards ROCK1/2. Phase 2.

    Features:Moderate preclinical tolerability, and PD characteristics of an AKT inhibitor. Distinct profile from other AKT inhibitors in clinical development.

  • Ipatasertib (GDC-0068)

    Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.

  • GSK690693

    GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.

  • Perifosine (KRX-0401)

    Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM in MM.1S cells, targets pleckstrin homology domain of Akt. Phase 3.

  • A-674563

    A-674563 is an Akt1 inhibitor with Ki of 11 nM in cell-free assays, modest potent to PKA and >30-fold selective for Akt1 over PKC.

    Features:Orally bioavailable compound (achieved by replacing indole of A-443654 with phenyl moiety) and somewhat less selective for Akt over PKA than A-443654.

  • Triciribine

    Triciribine is a DNA synthesis inhibitor, also inhibits Akt in PC3 cell line and HIV-1 in CEM-SS, H9, H9IIIB, U1 cells with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.

  • Honokiol

    Honokiol is the active principle of magnolia extract that inhibits Akt-phosphorylation and promotes ERK1/2 phosphorylation. Phase 3.

Recently Viewed Items

Tags: buy MK-2206 2HCl | MK-2206 2HCl supplier | purchase MK-2206 2HCl | MK-2206 2HCl cost | MK-2206 2HCl manufacturer | order MK-2206 2HCl | MK-2206 2HCl distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us